Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding

Acta Diabetologica

Volumn 51, Issue 3, 2014, Pages 361-368

  Folini, Laura ^a   Veronelli, Annamaria ^a   Benetti, Alberto ^a   Pozzato, Carlo ^b   Cappelletti, Marco ^c   Masci, Enzo ^b   Micheletto, Giancarlo ^d   Pontiroli, Antonio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c Servizio di Diagnostica Per Immagini Casa di Cura Igea   (Italy)

^d ISTITUTO CLINICO SANT'AMBROGIO   (Italy)

Author keywords

Bariatric surgery; Chemical shift magnetic resonance imaging; Gastric banding; Intragastric balloon; Liver enzymes; Liver steatosis; Obesity; Ultrasound

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; LIPID; LIVER ENZYME;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FAT FREE MASS; FAT MASS; FATTY LIVER; FEMALE; FOLLOW UP; GASTRIC BALLOON; GASTRIC BANDING; HUMAN; IMPEDANCE; INSULIN RESISTANCE; LOW CALORY DIET; MALE; METABOLISM; MORBID OBESITY; NUCLEAR MAGNETIC RESONANCE SCANNER; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADOLESCENT; AGED; BARIATRIC SURGERY; CLINICAL TRIAL; COMPLICATION; DEVICES; ENZYMOLOGY; LIVER; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY, MORBID; PATHOPHYSIOLOGY; RADIOGRAPHY; TREATMENT OUTCOME; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BARIATRIC SURGERY; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GASTRIC BALLOON; HUMANS; INSULIN; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84905273317     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0516-4     Document Type: Article

References (43)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727
2. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH (2002) Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 288:1758-1761
3. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241
4. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN (2008) Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8:200
5. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763-778 (Pubitemid 44285582)
6. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105 (Pubitemid 29466221)
7. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH, American Heart Association (2006) Obesity committee of the council on nutrition, physical activity, and metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 113: 898-918
8. Scott M (2004) Grundy obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595-2600
9. Marchesini G, Moscatiello S, Di Domizio S, Forlani G (2008) Obesity-associated liver disease. J Clin Endocrinol Metab 93(Suppl 1):S74-S80
10. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
11. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274-285
12. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005-2023
13. Fabbrini E, Conte C, Magkos F (2009) Methods for assessing intrahepatic fat content and steatosis. Current Opin Clin Nutr Metabol Care 12:474-481
14. Mazhar SM, Shiehmorteza M, Sirlin CB (2009) Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 7:135-140
15. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV(2009) Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 29:1253-1277
16. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ (2008) Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imag 28:937-945
17. Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, Kanel G, Buxton R (1991) Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 156:307-312
18. Thomsen C, Becker U, Winkler K (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495 (Pubitemid 24113193)
19. Cassidy FH, Yokoo T, Aganovic L, Hanna RF, Bydder M, Middleton MS, Hamilton G, Chavez AD, Schwimmer JB, Sirlin CB (2009) Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 29:231-260
20. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA (1997) Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15:287-293 (Pubitemid 27280484)
21. Fishbein M, Castro F, Cheruku S, Jain S, Webb B, Gleason T, Stevens WR (2005) Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39:619-625 (Pubitemid 41061269)
22. Suzuki A, Binks M, Sha R, Wachholtz A, Eisenson H, Diehl AM (2010) Serum aminotransferase changes with significant weight loss: sex and age effects. Metabolism 59:177-185
23. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51:121-129
24. Dixon JB, Bhathal PS, O'Brien PE (2006) Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 16:1278-1286 (Pubitemid 44671797)
25. Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB Jr, Alves VA, Carrilho FJ (2007) Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol 22:510-514 (Pubitemid 46434992)
26. Weiner RA (2010) Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis 28:274-279
27. Fishbein MH, Stevens WR (2001) Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Ped Radiol 31:806-809 (Pubitemid 33040146)
28. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745-750 (Pubitemid 34977081)
29. Saverymuttu SH, Joseph AEA, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292:13-15 (Pubitemid 16175875)
30. Fishbein MH, Miner M, Mogren C, Chalekson J (2003) The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J Pediatr Gastroenterol Nutr 36:54-61 (Pubitemid 41672620)
31. Fishbein MH, Mogren C, Gleason T, Ross Stevens W (2006) Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 42:83-88 (Pubitemid 43061015)
32. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Ferla G, Folli F (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555-3561 (Pubitemid 34879496)
33. Expert Panel on Detection (2001) Evaluation and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment Panel III). JAMA 285:2486-2497
34. Mottin CC, Moretto M, Padoin AV (2004) The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 14:635-637 (Pubitemid 38716583)
35. Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87-97
36. Pozzato C, Radaelli G, Dall'Asta C, Verduci E, Villa A, Villa C, Scaglioni S, Riva E, Pontiroli AE, Cornalba G, Giovannini M (2008) MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings. J Pediatr Gastroenterol Nutr 47:493-499
37. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A (2007) MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 96:542-547 (Pubitemid 46466114)
38. Xourafas D, Ardestani A, Ashley SW, Tavakkoli A (2012) Impact of weight-loss surgery and diabetes status on serum ALT levels. Obes Surg 22:1540-1547
39. Phillips ML, Boase S, Wahlroos S, Dugar M, Kow L, Stahl J, Slavotinek JP, Valentine R, Toouli J, Thompson CH (2008) Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery. Diabetes Obes Metab 10:661-667 (Pubitemid 352044296)
40. Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B, RISC Investigators (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537-1544
41. Williamson RM, Price JF, Glancy S, Perry E, Nee LD, Hayes PC, Frier BM, Van Look LA, Johnston GI, Reynolds RM, Strachan MW (2011) Edinburgh Type 2 Diabetes Study Investigators. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 34:1139-1144
42. Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L, Perseghin G (2011) Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 54:145-152
43. Pontiroli AE, Morabito A (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 253:484-487